Bladder tumor
Conditions
Interventions
Tumour resection with a snare is performed on eligible patients.ESR biopsy, cold cup biopsy and TUR biopsy are performed in patients who meet the indicated criteria and for whom random biopsy is recom
Sponsors
University of Jikei Kashiwa hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) 20 years of age or older 2) ECOG Performance Status 0-2 3) No other active multiple cancers (including hematological malignancies). 4) The patient has been informed of the disease, and written consent for participation in this study with his or her own will. 5) Less than 10 mm transverse to the tumor base and less than 3 tumors in the bladder. 6) Suspected intermediate or high risk on preoperative examination and scheduled for random biopsy for diagnostic purposes. 7) Patients with positive urine cytology without intravesical tumors and scheduled for random biopsy for diagnostic purposes. Patients must meet all of the criteria in 1) to 4) and one of the criteria in 5) to 7) for enrollment.
Exclusion criteria
Exclusion criteria: 1) Patients with poorly controlled infections (including active tuberculosis). 2) Patients with serious complications (malignant hypertension, severe congestive heart failure, severe coronary insufficiency, myocardial infarction within 3 months, end-stage liver cirrhosis, poorly controlled diabetes, severe pulmonary fibrosis, active interstitial pneumonia, etc.). 3) Patients in an immunocompromised state due to disease or treatment. 4) Patients with severe mental disorders. 5) Patients who are participating in other clinical studies (including clinical trials). 6) Patients who are pregnant or lactating mothers. 7) Patients who are deemed unsuitable by the principal investigator or sub-investigator due to medical, psychological or other factors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pathological evaluation of ESRBT specimens | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse event rate, operative time, muscle layer sampling rate, degree of thermal degeneration or destruction of tissue | — |
Countries
Japan
Contacts
Public ContactAkihiro Matsukawa
University of Jikei Kashiwa hospital Department of Urology
Outcome results
None listed